‘JW New Drug’ dealing with obesity treatment drugs provided unfair rebates to hospitals… Fair Commission, imposed fine

[세종=아시아경제 주상돈 기자] In order to increase the prescription of obesity treatment drugs that they manufacture and sell, JDW New Drug, which provided unfair rebates worth about 800 million won to hospitals and clinics, was sanctioned by the Fair Trade Commission.

The Fair Trade Commission announced on the 7th that it has decided to impose a correction order and a fine of 240 million won on the JD.

JDouble You New Drug handles a total of 18 types of obesity treatment drugs, including Pentermi, an appetite suppressant. In the market as a whole, products such as Novo Nordisk’s Saxenda (42.6 billion won), Daewoong Pharmaceutical’s’Dietamine (9.5 billion won)’, and Huons”Hutermin (6.2 billion won)’ take the top in sales.

According to the Fair Trade Commission, JDW New Drug provided unfair rebates worth about 800 million won to 90 hospitals and clinics nationwide for the purpose of increasing or maintaining the prescriptions of obesity drugs manufactured and sold by them from January 2014 to April 2017. .

A prescribed amount of prescription is contracted with each hospital and clinic, and in return, financial benefits (cash and goods support, etc.) equivalent to a certain percentage (20-35%) of the contracted prescription amount are provided in advance. After preliminary application, JDW new drug checked whether it was prescribed according to the actual contract, and if hospitals or clinics did not prescribe according to the contract, the implementation was managed by delaying the signing of a new contract or adjusting the rate of pre-application down the rate.

An official from the FTC said, “With this measure, we will strict the provision of unfair rebates in the obesity treatment market, which is a prescription drug, to correct the competitive order and to protect consumer interests.” He said, “We plan to continuously strengthen the monitoring of behaviors that hinder the law, and if any violations of related laws are found, we will strictly sanction them in accordance with the principle.”

Reporter Joo Sang-don [email protected]